FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double
Top Story
Archived
•
August 26, 2026
•
Revolution Medicines' Rasonque targets the RAS protein driving 95% of pancreatic adenocarcinoma cases, offering a critical option after chemotherapy fails.
Source: FoxNews | https://feeds.feedburner.com/foxnews/latest - Read Original
"House Plans for Structures New and Old"
"Commision Art Work or Just pure Beauty."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"5000+ Emails weekly."
"Adventure is where you chose to go."